Bigul

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

In compliance of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below schedule of upcoming Investor Meetings with the Management of Fortis Healthcare Limited ('FHL'), to discuss about the general business update and the industry in which the Company operates Date Day & Time: September 5, 2023 (Tuesday) at 09 am Location Mumbai A detailed disclosure is attached.
01-09-2023
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Resignation of Director

Pursuant to Regulation 30 of SEBI LODR, this is to inform you Mr. Heng Joo Joe Sim has resigned from the position of Non-executive & Non-Independent Director of the Company w.e.f. September 1, 2023 Detailed disclosure is enclosed.
01-09-2023
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Change in Management

This is to inform you that Mr. Rajiv Puri- Head Risk and Internal Audit of the Company, has resigned w.e.f. August 31, 2023 (from the close of business hours). The detailed disclosure as required under Regulation 30 of SEBI LODR is attached.
31-08-2023

Fortis Healthcare to acquire Medeor Hospital Manesar for Rs 225 crore; shares gain

The share touched a 52-week high of Rs 352 and a 52-week low of Rs 245.40 on 31 July, 2023 and 24 March, 2023, respectively.
31-08-2023
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Ref: Email Received From BSE On August 30, 2023 With Respect To Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations, 2015. Sub: Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 In Relation To Consummation Of Transaction Related To Acquisition Of Medeor Hospital, Manesar

This is in reference to your email dated August 30, 2023, seeking additional details required for Corporate Announcement filed under regulation 30 of SEBI LODR by the Company on August 29, 2023 intimating consummation of the proposed transaction for the acquisition of a multi-speciality hospital situated in Sector-5, IMT Manesar, Tehsil & District, Gurgaon, Haryana ("Medeor Hospital Manesar") along with all structures and buildings as well as the movable assets present at Medeor Hospital Manesar. The detailed disclosure is attached.
30-08-2023
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 In In Relation To Consummation Of Transaction Related To Acquisition Of Medeor Hospital, Manesar.

We would like to inform you that the Company has consummated the proposed transaction for acquisition of a multi- speciality hospital situated in Sector-5, IMT- Manesar, Tehsil and District, Gurgaon, Haryana (''Medeor Manesar Hospital'') along with all the structures and buildings as well as the moveable assets present at Medeor Hospital Manesar on such terms and conditions as contained in the relevant definitive agreements. The detailed disclosure is attached.
29-08-2023
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Update On Material Litigation Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

This is in continuation to our letter dated August 14, 2023, pursuant to Regulation 30 of SEBI LODR read with SEBI Circular dated July 13, 2023 and specifically the matter disclosed at Point XIV at page no. 387 of Annual Report of the Company for FY 2022-23. In this regard, the detailed disclosure w.r.t. writ petition filed by Fortis Health Management Limited, a subsidiary of the Company, before the Hon''ble Madras High Court is enclosed herewith.
28-08-2023
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for My Asian Strategic Metric Master, L.P. & Others
28-08-2023
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Update On Material Litigation Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

This is in continuation to our letter dated August 14, 2023, pursuant to Reg. 30 of SEBI LODR read with SEBI circular dated July 13, 2023. In this regard, please find enclosed disclosure regarding settlement agreement in the pending medical litigation in Fortis Hospitals Limited, a material subsidiary of the Company.
22-08-2023
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Disclosure Of Continuing Events That Have Now Become Material Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 Amended Vide The SEBI (Listing Obligations & Disclosure Requirements) (Second Amendment) Regulations, 2023

Pursuant to Reg. 30 of SEBI LODR Regulations 2015 and SEBI LODR (Second Amendment) Regulations 2023, the details of pending litigations, in addition to disclosures given in Annual Report and that are now categorized as material considering revised materiality threshold of the Company are enclosed herewith.
14-08-2023
Next Page
Close

Let's Open Free Demat Account